article · Transactions of the Royal Society of Tropical Medicine and Hygiene
BACKGROUND: Cryptosporidium is an important enteric parasite causing diarrhoea in humans and animals worldwide. Data on the molecular epidemiology of Cryptosporidium infection in adults in Zambia are limited. METHODS: A total of 566 stool samples from adults (18-50 years) were examined for Cryptosporidium oocysts by light microscopy following modified Ziehl-Neelsen staining. Molecular analysis of positive samples targeted the 60-kDa glycoprotein and heat shock protein 70-kDa genes. Demographic and potential risk factor information was obtained by semi-structured closed questionnaires. RESULTS: The prevalence of Cryptosporidium infection was 3.0% (17/566), affecting a higher proportion of people living with human immunodeficiency virus (HIV) compared with HIV-negative participants, with a significantly higher prevalence among people living with HIV not using antiretroviral therapy (ART) (p=0.001). Additional associated factors included the use of municipal water (p=0.016), moderate monthly income (p=0.01), watery stool and frequent diarrhoea (p=0.001) and haemoglobin levels <10 g/dl (p=0.001). Both Cryptosporidium parvum and Cryptosporidium hominis were identified and all C. parvum subtypes were associated with anthroponotic transmission (IIiA9 [n=4], IIiA6 [n=2], IIeA11G1 [n=1] and IIcA5G3 [n=2]). For C. hominis subtypes, IeA11G3T3 (n=2), IaA26R3 (n=1) and IdA13 (n=1) were identified. CONCLUSION: Cryptosporidium infection continues to be a significant issue among individuals living with HIV. Health education focusing on reducing anthroponotic transmission routes should be a priority.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1093/trstmh/trag079
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.